カテゴリー： 世界, 医療/バイオ, LP Information

世界の医療用核酸迅速ハイブリダイゼーション装置市場予測 2023年-2029年

【英語タイトル】Global Medical Nucleic Acid Rapid Hybridization Instrument Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC07581）・商品コード：LP23DC07581
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：97
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の医療用核酸迅速ハイブリダイゼーション装置市場」は、過去の販売実績から2022年の世界の医療用核酸迅速ハイブリダイゼーション装置の総販売量を検討し、2023年から2029年の予測される医療用核酸迅速ハイブリダイゼーション装置の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の医療用核酸迅速ハイブリダイゼーション装置の市場規模を掲載し、XXX百万米ドル規模の世界の医療用核酸迅速ハイブリダイゼーション装置市場の詳細な分析を提供します。本インサイトレポートは、世界の医療用核酸迅速ハイブリダイゼーション装置業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の医療用核酸迅速ハイブリダイゼーション装置市場における各社の独自のポジションをより深く理解するために、医療用核酸迅速ハイブリダイゼーション装置製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の医療用核酸迅速ハイブリダイゼーション装置市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。医療用核酸迅速ハイブリダイゼーション装置の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。医療用核酸迅速ハイブリダイゼーション装置の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。医療用核酸迅速ハイブリダイゼーション装置のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

医療用核酸迅速ハイブリダイゼーション装置の世界主要メーカーとしては、Analytikjena、 ACON、 Hybribio、 Sichuan PUTS Biotech、 Yaneng BIO、 Xiamen Zeesan Biotechなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の医療用核酸迅速ハイブリダイゼーション装置市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では医療用核酸迅速ハイブリダイゼーション装置市場をセグメンテーションし、種類別 (固相核酸分子ハイブリダイゼーション、液相核酸分子ハイブリダイゼーション)、用途別 (病院、研究機関)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：固相核酸分子ハイブリダイゼーション、液相核酸分子ハイブリダイゼーション

・用途別区分：病院、研究機関

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の医療用核酸迅速ハイブリダイゼーション装置市場の10年間の市場状況・展望は？
・世界および地域別に見た医療用核酸迅速ハイブリダイゼーション装置市場成長の要因は何か？
・医療用核酸迅速ハイブリダイゼーション装置の市場機会はエンドマーケットの規模によってどのように変化するのか？
・医療用核酸迅速ハイブリダイゼーション装置のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：医療用核酸迅速ハイブリダイゼーション装置の年間販売量2018-2029、地域別現状・将来分析
・医療用核酸迅速ハイブリダイゼーション装置の種類別セグメント：固相核酸分子ハイブリダイゼーション、液相核酸分子ハイブリダイゼーション
・医療用核酸迅速ハイブリダイゼーション装置の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・医療用核酸迅速ハイブリダイゼーション装置の用途別セグメント：病院、研究機関
・医療用核酸迅速ハイブリダイゼーション装置の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の医療用核酸迅速ハイブリダイゼーション装置市場
・企業別のグローバル医療用核酸迅速ハイブリダイゼーション装置市場データ：2018-2023年の年間販売量、市場シェア
・企業別の医療用核酸迅速ハイブリダイゼーション装置の年間売上：2018-2023年の売上、市場シェア
・企業別の医療用核酸迅速ハイブリダイゼーション装置販売価格
・主要企業の医療用核酸迅速ハイブリダイゼーション装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

医療用核酸迅速ハイブリダイゼーション装置の地域別レビュー
・地域別の医療用核酸迅速ハイブリダイゼーション装置市場規模2018-2023：年間販売量、売上
・主要国別の医療用核酸迅速ハイブリダイゼーション装置市場規模2018-2023：年間販売量、売上
・南北アメリカの医療用核酸迅速ハイブリダイゼーション装置販売の成長
・アジア太平洋の医療用核酸迅速ハイブリダイゼーション装置販売の成長
・ヨーロッパの医療用核酸迅速ハイブリダイゼーション装置販売の成長
・中東・アフリカの医療用核酸迅速ハイブリダイゼーション装置販売の成長

南北アメリカ市場
・南北アメリカの国別の医療用核酸迅速ハイブリダイゼーション装置販売量、売上（2018-2023）
・南北アメリカの医療用核酸迅速ハイブリダイゼーション装置の種類別販売量
・南北アメリカの医療用核酸迅速ハイブリダイゼーション装置の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の医療用核酸迅速ハイブリダイゼーション装置販売量、売上（2018-2023）
・アジア太平洋の医療用核酸迅速ハイブリダイゼーション装置の種類別販売量
・アジア太平洋の医療用核酸迅速ハイブリダイゼーション装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の医療用核酸迅速ハイブリダイゼーション装置販売量、売上（2018-2023）
・ヨーロッパの医療用核酸迅速ハイブリダイゼーション装置の種類別販売量
・ヨーロッパの医療用核酸迅速ハイブリダイゼーション装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の医療用核酸迅速ハイブリダイゼーション装置販売量、売上（2018-2023）
・中東・アフリカの医療用核酸迅速ハイブリダイゼーション装置の種類別販売量
・中東・アフリカの医療用核酸迅速ハイブリダイゼーション装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・医療用核酸迅速ハイブリダイゼーション装置の製造コスト構造分析
・医療用核酸迅速ハイブリダイゼーション装置の製造プロセス分析
・医療用核酸迅速ハイブリダイゼーション装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・医療用核酸迅速ハイブリダイゼーション装置の主要なグローバル販売業者
・医療用核酸迅速ハイブリダイゼーション装置の主要なグローバル顧客

地域別の医療用核酸迅速ハイブリダイゼーション装置市場予測レビュー
・地域別の医療用核酸迅速ハイブリダイゼーション装置市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・医療用核酸迅速ハイブリダイゼーション装置の種類別市場規模予測
・医療用核酸迅速ハイブリダイゼーション装置の用途別市場規模予測

主要企業分析
Analytikjena、 ACON、 Hybribio、 Sichuan PUTS Biotech、 Yaneng BIO、 Xiamen Zeesan Biotech
・企業情報
・医療用核酸迅速ハイブリダイゼーション装置製品
・医療用核酸迅速ハイブリダイゼーション装置販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Medical Nucleic Acid Rapid Hybridization Instrument market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Medical Nucleic Acid Rapid Hybridization Instrument is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Medical Nucleic Acid Rapid Hybridization Instrument is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Medical Nucleic Acid Rapid Hybridization Instrument is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Medical Nucleic Acid Rapid Hybridization Instrument players cover Analytikjena, ACON, Hybribio, Sichuan PUTS Biotech, Yaneng BIO and Xiamen Zeesan Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Medical Nucleic Acid Rapid Hybridization Instrument Industry Forecast” looks at past sales and reviews total world Medical Nucleic Acid Rapid Hybridization Instrument sales in 2022, providing a comprehensive analysis by region and market sector of projected Medical Nucleic Acid Rapid Hybridization Instrument sales for 2023 through 2029. With Medical Nucleic Acid Rapid Hybridization Instrument sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Nucleic Acid Rapid Hybridization Instrument industry.
This Insight Report provides a comprehensive analysis of the global Medical Nucleic Acid Rapid Hybridization Instrument landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Nucleic Acid Rapid Hybridization Instrument portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Nucleic Acid Rapid Hybridization Instrument market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Nucleic Acid Rapid Hybridization Instrument and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Nucleic Acid Rapid Hybridization Instrument.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Nucleic Acid Rapid Hybridization Instrument market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Solid Phase Nucleic Acid Molecular Hybridization
Liquid Phase Nucleic Acid Molecular Hybridization
Segmentation by application
Hospital
Research Institutions
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Analytikjena
ACON
Hybribio
Sichuan PUTS Biotech
Yaneng BIO
Xiamen Zeesan Biotech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Medical Nucleic Acid Rapid Hybridization Instrument market?
What factors are driving Medical Nucleic Acid Rapid Hybridization Instrument market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Nucleic Acid Rapid Hybridization Instrument market opportunities vary by end market size?
How does Medical Nucleic Acid Rapid Hybridization Instrument break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Nucleic Acid Rapid Hybridization Instrument Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Medical Nucleic Acid Rapid Hybridization Instrument by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Medical Nucleic Acid Rapid Hybridization Instrument by Country/Region, 2018, 2022 & 2029
2.2 Medical Nucleic Acid Rapid Hybridization Instrument Segment by Type
2.2.1 Solid Phase Nucleic Acid Molecular Hybridization
2.2.2 Liquid Phase Nucleic Acid Molecular Hybridization
2.3 Medical Nucleic Acid Rapid Hybridization Instrument Sales by Type
2.3.1 Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Type (2018-2023)
2.3.2 Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue and Market Share by Type (2018-2023)
2.3.3 Global Medical Nucleic Acid Rapid Hybridization Instrument Sale Price by Type (2018-2023)
2.4 Medical Nucleic Acid Rapid Hybridization Instrument Segment by Application
2.4.1 Hospital
2.4.2 Research Institutions
2.5 Medical Nucleic Acid Rapid Hybridization Instrument Sales by Application
2.5.1 Global Medical Nucleic Acid Rapid Hybridization Instrument Sale Market Share by Application (2018-2023)
2.5.2 Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue and Market Share by Application (2018-2023)
2.5.3 Global Medical Nucleic Acid Rapid Hybridization Instrument Sale Price by Application (2018-2023)
3 Global Medical Nucleic Acid Rapid Hybridization Instrument by Company
3.1 Global Medical Nucleic Acid Rapid Hybridization Instrument Breakdown Data by Company
3.1.1 Global Medical Nucleic Acid Rapid Hybridization Instrument Annual Sales by Company (2018-2023)
3.1.2 Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Company (2018-2023)
3.2 Global Medical Nucleic Acid Rapid Hybridization Instrument Annual Revenue by Company (2018-2023)
3.2.1 Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Company (2018-2023)
3.2.2 Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Company (2018-2023)
3.3 Global Medical Nucleic Acid Rapid Hybridization Instrument Sale Price by Company
3.4 Key Manufacturers Medical Nucleic Acid Rapid Hybridization Instrument Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Nucleic Acid Rapid Hybridization Instrument Product Location Distribution
3.4.2 Players Medical Nucleic Acid Rapid Hybridization Instrument Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Medical Nucleic Acid Rapid Hybridization Instrument by Geographic Region
4.1 World Historic Medical Nucleic Acid Rapid Hybridization Instrument Market Size by Geographic Region (2018-2023)
4.1.1 Global Medical Nucleic Acid Rapid Hybridization Instrument Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Medical Nucleic Acid Rapid Hybridization Instrument Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Medical Nucleic Acid Rapid Hybridization Instrument Market Size by Country/Region (2018-2023)
4.2.1 Global Medical Nucleic Acid Rapid Hybridization Instrument Annual Sales by Country/Region (2018-2023)
4.2.2 Global Medical Nucleic Acid Rapid Hybridization Instrument Annual Revenue by Country/Region (2018-2023)
4.3 Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales Growth
4.4 APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales Growth
4.5 Europe Medical Nucleic Acid Rapid Hybridization Instrument Sales Growth
4.6 Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Sales Growth
5 Americas
5.1 Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales by Country
5.1.1 Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales by Country (2018-2023)
5.1.2 Americas Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Country (2018-2023)
5.2 Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales by Type
5.3 Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales by Region
6.1.1 APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales by Region (2018-2023)
6.1.2 APAC Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Region (2018-2023)
6.2 APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales by Type
6.3 APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical Nucleic Acid Rapid Hybridization Instrument by Country
7.1.1 Europe Medical Nucleic Acid Rapid Hybridization Instrument Sales by Country (2018-2023)
7.1.2 Europe Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Country (2018-2023)
7.2 Europe Medical Nucleic Acid Rapid Hybridization Instrument Sales by Type
7.3 Europe Medical Nucleic Acid Rapid Hybridization Instrument Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument by Country
8.1.1 Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Sales by Country (2018-2023)
8.1.2 Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Country (2018-2023)
8.2 Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Sales by Type
8.3 Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Nucleic Acid Rapid Hybridization Instrument
10.3 Manufacturing Process Analysis of Medical Nucleic Acid Rapid Hybridization Instrument
10.4 Industry Chain Structure of Medical Nucleic Acid Rapid Hybridization Instrument
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Nucleic Acid Rapid Hybridization Instrument Distributors
11.3 Medical Nucleic Acid Rapid Hybridization Instrument Customer
12 World Forecast Review for Medical Nucleic Acid Rapid Hybridization Instrument by Geographic Region
12.1 Global Medical Nucleic Acid Rapid Hybridization Instrument Market Size Forecast by Region
12.1.1 Global Medical Nucleic Acid Rapid Hybridization Instrument Forecast by Region (2024-2029)
12.1.2 Global Medical Nucleic Acid Rapid Hybridization Instrument Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical Nucleic Acid Rapid Hybridization Instrument Forecast by Type
12.7 Global Medical Nucleic Acid Rapid Hybridization Instrument Forecast by Application
13 Key Players Analysis
13.1 Analytikjena
13.1.1 Analytikjena Company Information
13.1.2 Analytikjena Medical Nucleic Acid Rapid Hybridization Instrument Product Portfolios and Specifications
13.1.3 Analytikjena Medical Nucleic Acid Rapid Hybridization Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Analytikjena Main Business Overview
13.1.5 Analytikjena Latest Developments
13.2 ACON
13.2.1 ACON Company Information
13.2.2 ACON Medical Nucleic Acid Rapid Hybridization Instrument Product Portfolios and Specifications
13.2.3 ACON Medical Nucleic Acid Rapid Hybridization Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 ACON Main Business Overview
13.2.5 ACON Latest Developments
13.3 Hybribio
13.3.1 Hybribio Company Information
13.3.2 Hybribio Medical Nucleic Acid Rapid Hybridization Instrument Product Portfolios and Specifications
13.3.3 Hybribio Medical Nucleic Acid Rapid Hybridization Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hybribio Main Business Overview
13.3.5 Hybribio Latest Developments
13.4 Sichuan PUTS Biotech
13.4.1 Sichuan PUTS Biotech Company Information
13.4.2 Sichuan PUTS Biotech Medical Nucleic Acid Rapid Hybridization Instrument Product Portfolios and Specifications
13.4.3 Sichuan PUTS Biotech Medical Nucleic Acid Rapid Hybridization Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sichuan PUTS Biotech Main Business Overview
13.4.5 Sichuan PUTS Biotech Latest Developments
13.5 Yaneng BIO
13.5.1 Yaneng BIO Company Information
13.5.2 Yaneng BIO Medical Nucleic Acid Rapid Hybridization Instrument Product Portfolios and Specifications
13.5.3 Yaneng BIO Medical Nucleic Acid Rapid Hybridization Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Yaneng BIO Main Business Overview
13.5.5 Yaneng BIO Latest Developments
13.6 Xiamen Zeesan Biotech
13.6.1 Xiamen Zeesan Biotech Company Information
13.6.2 Xiamen Zeesan Biotech Medical Nucleic Acid Rapid Hybridization Instrument Product Portfolios and Specifications
13.6.3 Xiamen Zeesan Biotech Medical Nucleic Acid Rapid Hybridization Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Xiamen Zeesan Biotech Main Business Overview
13.6.5 Xiamen Zeesan Biotech Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Medical Nucleic Acid Rapid Hybridization Instrument Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Medical Nucleic Acid Rapid Hybridization Instrument Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Solid Phase Nucleic Acid Molecular Hybridization
Table 4. Major Players of Liquid Phase Nucleic Acid Molecular Hybridization
Table 5. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales by Type (2018-2023) & (Units)
Table 6. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Type (2018-2023)
Table 7. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Type (2018-2023) & ($ million)
Table 8. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Type (2018-2023)
Table 9. Global Medical Nucleic Acid Rapid Hybridization Instrument Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales by Application (2018-2023) & (Units)
Table 11. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Application (2018-2023)
Table 12. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Application (2018-2023)
Table 13. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Application (2018-2023)
Table 14. Global Medical Nucleic Acid Rapid Hybridization Instrument Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales by Company (2018-2023) & (Units)
Table 16. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Company (2018-2023)
Table 17. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Company (2018-2023)
Table 19. Global Medical Nucleic Acid Rapid Hybridization Instrument Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Medical Nucleic Acid Rapid Hybridization Instrument Producing Area Distribution and Sales Area
Table 21. Players Medical Nucleic Acid Rapid Hybridization Instrument Products Offered
Table 22. Medical Nucleic Acid Rapid Hybridization Instrument Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share Geographic Region (2018-2023)
Table 27. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Country/Region (2018-2023)
Table 31. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales by Country (2018-2023) & (Units)
Table 34. Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Country (2018-2023)
Table 35. Americas Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Country (2018-2023)
Table 37. Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales by Type (2018-2023) & (Units)
Table 38. Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales by Application (2018-2023) & (Units)
Table 39. APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales by Region (2018-2023) & (Units)
Table 40. APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Region (2018-2023)
Table 41. APAC Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Region (2018-2023)
Table 43. APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales by Type (2018-2023) & (Units)
Table 44. APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales by Application (2018-2023) & (Units)
Table 45. Europe Medical Nucleic Acid Rapid Hybridization Instrument Sales by Country (2018-2023) & (Units)
Table 46. Europe Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Country (2018-2023)
Table 47. Europe Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Country (2018-2023)
Table 49. Europe Medical Nucleic Acid Rapid Hybridization Instrument Sales by Type (2018-2023) & (Units)
Table 50. Europe Medical Nucleic Acid Rapid Hybridization Instrument Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Medical Nucleic Acid Rapid Hybridization Instrument
Table 58. Key Market Challenges & Risks of Medical Nucleic Acid Rapid Hybridization Instrument
Table 59. Key Industry Trends of Medical Nucleic Acid Rapid Hybridization Instrument
Table 60. Medical Nucleic Acid Rapid Hybridization Instrument Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Medical Nucleic Acid Rapid Hybridization Instrument Distributors List
Table 63. Medical Nucleic Acid Rapid Hybridization Instrument Customer List
Table 64. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Medical Nucleic Acid Rapid Hybridization Instrument Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Medical Nucleic Acid Rapid Hybridization Instrument Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Medical Nucleic Acid Rapid Hybridization Instrument Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Medical Nucleic Acid Rapid Hybridization Instrument Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Analytikjena Basic Information, Medical Nucleic Acid Rapid Hybridization Instrument Manufacturing Base, Sales Area and Its Competitors
Table 79. Analytikjena Medical Nucleic Acid Rapid Hybridization Instrument Product Portfolios and Specifications
Table 80. Analytikjena Medical Nucleic Acid Rapid Hybridization Instrument Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Analytikjena Main Business
Table 82. Analytikjena Latest Developments
Table 83. ACON Basic Information, Medical Nucleic Acid Rapid Hybridization Instrument Manufacturing Base, Sales Area and Its Competitors
Table 84. ACON Medical Nucleic Acid Rapid Hybridization Instrument Product Portfolios and Specifications
Table 85. ACON Medical Nucleic Acid Rapid Hybridization Instrument Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. ACON Main Business
Table 87. ACON Latest Developments
Table 88. Hybribio Basic Information, Medical Nucleic Acid Rapid Hybridization Instrument Manufacturing Base, Sales Area and Its Competitors
Table 89. Hybribio Medical Nucleic Acid Rapid Hybridization Instrument Product Portfolios and Specifications
Table 90. Hybribio Medical Nucleic Acid Rapid Hybridization Instrument Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Hybribio Main Business
Table 92. Hybribio Latest Developments
Table 93. Sichuan PUTS Biotech Basic Information, Medical Nucleic Acid Rapid Hybridization Instrument Manufacturing Base, Sales Area and Its Competitors
Table 94. Sichuan PUTS Biotech Medical Nucleic Acid Rapid Hybridization Instrument Product Portfolios and Specifications
Table 95. Sichuan PUTS Biotech Medical Nucleic Acid Rapid Hybridization Instrument Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Sichuan PUTS Biotech Main Business
Table 97. Sichuan PUTS Biotech Latest Developments
Table 98. Yaneng BIO Basic Information, Medical Nucleic Acid Rapid Hybridization Instrument Manufacturing Base, Sales Area and Its Competitors
Table 99. Yaneng BIO Medical Nucleic Acid Rapid Hybridization Instrument Product Portfolios and Specifications
Table 100. Yaneng BIO Medical Nucleic Acid Rapid Hybridization Instrument Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Yaneng BIO Main Business
Table 102. Yaneng BIO Latest Developments
Table 103. Xiamen Zeesan Biotech Basic Information, Medical Nucleic Acid Rapid Hybridization Instrument Manufacturing Base, Sales Area and Its Competitors
Table 104. Xiamen Zeesan Biotech Medical Nucleic Acid Rapid Hybridization Instrument Product Portfolios and Specifications
Table 105. Xiamen Zeesan Biotech Medical Nucleic Acid Rapid Hybridization Instrument Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Xiamen Zeesan Biotech Main Business
Table 107. Xiamen Zeesan Biotech Latest Developments
List of Figures
Figure 1. Picture of Medical Nucleic Acid Rapid Hybridization Instrument
Figure 2. Medical Nucleic Acid Rapid Hybridization Instrument Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Medical Nucleic Acid Rapid Hybridization Instrument Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Solid Phase Nucleic Acid Molecular Hybridization
Figure 10. Product Picture of Liquid Phase Nucleic Acid Molecular Hybridization
Figure 11. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Type in 2022
Figure 12. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Type (2018-2023)
Figure 13. Medical Nucleic Acid Rapid Hybridization Instrument Consumed in Hospital
Figure 14. Global Medical Nucleic Acid Rapid Hybridization Instrument Market: Hospital (2018-2023) & (Units)
Figure 15. Medical Nucleic Acid Rapid Hybridization Instrument Consumed in Research Institutions
Figure 16. Global Medical Nucleic Acid Rapid Hybridization Instrument Market: Research Institutions (2018-2023) & (Units)
Figure 17. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Application (2022)
Figure 18. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Application in 2022
Figure 19. Medical Nucleic Acid Rapid Hybridization Instrument Sales Market by Company in 2022 (Units)
Figure 20. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Company in 2022
Figure 21. Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Company in 2022
Figure 23. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales 2018-2023 (Units)
Figure 26. Americas Medical Nucleic Acid Rapid Hybridization Instrument Revenue 2018-2023 ($ Millions)
Figure 27. APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales 2018-2023 (Units)
Figure 28. APAC Medical Nucleic Acid Rapid Hybridization Instrument Revenue 2018-2023 ($ Millions)
Figure 29. Europe Medical Nucleic Acid Rapid Hybridization Instrument Sales 2018-2023 (Units)
Figure 30. Europe Medical Nucleic Acid Rapid Hybridization Instrument Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Sales 2018-2023 (Units)
Figure 32. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Revenue 2018-2023 ($ Millions)
Figure 33. Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Country in 2022
Figure 34. Americas Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Country in 2022
Figure 35. Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Type (2018-2023)
Figure 36. Americas Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Application (2018-2023)
Figure 37. United States Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Region in 2022
Figure 42. APAC Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Regions in 2022
Figure 43. APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Type (2018-2023)
Figure 44. APAC Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Application (2018-2023)
Figure 45. China Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Country in 2022
Figure 53. Europe Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Country in 2022
Figure 54. Europe Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Type (2018-2023)
Figure 55. Europe Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Application (2018-2023)
Figure 56. Germany Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share by Application (2018-2023)
Figure 65. Egypt Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Medical Nucleic Acid Rapid Hybridization Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Medical Nucleic Acid Rapid Hybridization Instrument in 2022
Figure 71. Manufacturing Process Analysis of Medical Nucleic Acid Rapid Hybridization Instrument
Figure 72. Industry Chain Structure of Medical Nucleic Acid Rapid Hybridization Instrument
Figure 73. Channels of Distribution
Figure 74. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Forecast by Region (2024-2029)
Figure 75. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Medical Nucleic Acid Rapid Hybridization Instrument Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Medical Nucleic Acid Rapid Hybridization Instrument Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の医療用核酸迅速ハイブリダイゼーション装置市場予測 2023年-2029年] (コード：LP23DC07581)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の医療用核酸迅速ハイブリダイゼーション装置市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の呼吸器用病原体キット市場予測 2023年-2029年
  • 世界の迅速診断試薬用充填剤市場予測 2023年-2029年
  • 世界の医療用検針器市場予測 2023年-2029年
  • 世界の5-アミノレブリン酸誘導体市場予測 2023年-2029年
  • 世界の医療用物理計測器市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆